Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics
Clinical trial NCT05077631 · COMPLETED
Trial details
- NCT number
- NCT05077631
- Sponsor
- AlzeCure Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-15
- Primary completion
- 2022-02-22
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.